Elaine R. Mardis's most recent trade in Singular Genomics Systems Inc was a trade of 74,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Singular Genomics Systems Inc | Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
Singular Genomics Systems Inc | Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
Singular Genomics Systems Inc | Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,271 | 19,271 | - | - | Stock Option (Right to Buy) | |
Singular Genomics Systems Inc | Elaine R. Mardis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |